BioArctic revenue and financials
In the fiscal year ended December 2025, BioArctic reported revenue of kr 2B (+676.80% year over year). Net income was kr 1.02B, a net margin of 51.1%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +676.80%
- 2025 vs 2024
- Net margin
- 51.1%
- 2024: -68.8%
How BioArctic is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 98.3% a year on average over the last 5 years
Compound annual growth rate: from kr 65.21M in 2020 to kr 2B in 2025.
Operating margin rose from −3.5% to 68.4%
Operating income over revenue, 2022 → 2025: 71.9 percentage points.
Profits turn into cash: free cash flow equal to 128% of net income
Totals for fiscal years 2023–2025: free cash flow kr 1.38B, net income kr 1.07B.
Profitable in 2 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,999 | 257 | 616 | 229 | 25.7 | 65.2 | 283 | 722 | 157 | 106 |
| Cost of revenue | 59.2 | 27.0 | 15.0 | 74.3 | 55.1 | 50.2 | 72.4 | 145 | 63.6 | 0.2 |
| Gross profit | 1,940 | 230 | 601 | 155 | -29.4 | 15.0 | 211 | 577 | 93.2 | 105 |
| Selling, general and administrative | 195 | 149 | 172 | 149 | 97.4 | 86.3 | 90.9 | 89.0 | 69.1 | 15.9 |
| Research and development | 377 | 311 | 172 | — | — | — | — | — | — | 53.7 |
| Operating income | 1,368 | -230 | 257 | -7.9 | -140 | -82.3 | 111 | 486 | 24.0 | 62.7 |
| EBIT | 1,368 | -230 | 257 | -7.9 | -140 | -82.3 | 111 | 486 | 24.0 | 62.7 |
| EBITDA | 1,270 | -211 | 275 | -1.9 | -135 | -78.5 | 114 | 488 | 26.0 | 64.2 |
| Interest expense | 2.0 | 0.0 | 0.3 | 0.6 | 0.8 | 1.0 | 1.2 | 1.4 | 0.6 | 0.0 |
| Pre-tax income | 1,256 | -190 | 276 | -11.2 | -141 | -86.7 | 113 | 490 | 19.7 | 74.1 |
| Income tax | 233 | -12.4 | 47.2 | 0.0 | -20.7 | -18.2 | 24.5 | 108 | 4.5 | 16.6 |
| Net income | 1,022 | -177 | 229 | -11.2 | -120 | -68.5 | 88.5 | 382 | 15.2 | 57.6 |
| Net income to common shareholders | 1,022 | -177 | 229 | -11.2 | -120 | -68.5 | 88.5 | 382 | 15.2 | 57.6 |
| Basic EPS | 11.55 | -2.00 | 2.60 | -0.13 | -1.36 | -0.78 | 1.00 | 4.33 | 0.22 | 0.91 |
| Diluted EPS | 11.52 | -2.00 | 2.59 | -0.13 | -1.36 | -0.78 | 1.00 | 4.33 | 0.22 | 0.91 |
| Average shares (basic) | 88.5 | 88.3 | 88.2 | 88.1 | 88.1 | 88.1 | 88.1 | 88.1 | 68.1 | 63.1 |
| Average shares (diluted) | 88.7 | 88.5 | 88.5 | 88.7 | 88.1 | 88.1 | 88.1 | 88.1 | 68.1 | 63.1 |
| Dividend per share | 2.00 | — | — | — | — | — | — | 1.50 | — | — |
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 248 | 438 | 184 | 133 | 392 | 1,290 | 101 | 76.6 | 49.8 | 29.6 | 11.0 | 209 |
| Cost of revenue | 21.7 | 19.5 | 15.1 | 12.2 | 20.5 | 11.4 | 11.8 | 8.1 | 4.8 | 2.2 | 0.7 | 0.3 |
| Gross profit | 226 | 418 | 169 | 121 | 372 | 1,278 | 89.4 | 68.5 | 45.0 | 27.4 | 10.3 | 209 |
| Selling, general and administrative | 58.4 | 52.4 | 49.4 | 50.3 | 49.1 | 46.0 | 46.5 | 26.6 | 36.9 | 38.8 | 38.7 | 38.9 |
| Research and development | 170 | 151 | 84.9 | 95.5 | 112 | 84.6 | 96.3 | 68.4 | 83.5 | 63.0 | 51.3 | 32.7 |
| Operating income | -14.3 | 201 | 27.2 | -22.2 | 211 | 1,074 | -56.7 | -25.6 | -74.9 | -75.1 | -83.0 | 137 |
| EBIT | -14.3 | 201 | 27.2 | -22.2 | 211 | 1,074 | -56.7 | -25.6 | -74.9 | -75.1 | -83.0 | 137 |
| EBITDA | -11.0 | 204 | 44.0 | -18.3 | 214 | 1,078 | -52.1 | -21.0 | -72.8 | -73.0 | -78.2 | 142 |
| Interest expense | 1.0 | 0.5 | 4.9 | 2.7 | 16.1 | 14.2 | — | 0.6 | 0.5 | 0.1 | — | 0.3 |
| Pre-tax income | 6.4 | 224 | 39.1 | -20.9 | 171 | 1,066 | -43.9 | -19.7 | -68.4 | -57.5 | -75.7 | 141 |
| Income tax | 17.5 | 11.7 | 47.9 | 65.9 | 74.9 | 44.5 | -12.4 | -0.1 | -0.0 | 0.1 | 11.6 | 15.6 |
| Net income | -11.2 | 212 | -8.8 | -86.9 | 96.6 | 1,021 | -31.5 | -19.6 | -68.4 | -57.6 | -87.2 | 125 |
| Net income to common shareholders | -11.2 | 212 | -8.8 | -86.9 | 96.6 | 1,021 | -31.5 | -19.6 | -68.4 | -57.6 | -87.2 | 125 |
| Basic EPS | -0.13 | 2.40 | -0.10 | -0.98 | 1.09 | 11.55 | -0.36 | -0.22 | -0.77 | -0.65 | -0.99 | 1.42 |
| Diluted EPS | -0.13 | 2.39 | -0.10 | -0.98 | 1.09 | 11.53 | -0.36 | -0.22 | -0.77 | -0.65 | -0.99 | 1.41 |
| Average shares (basic) | 88.7 | 88.6 | 88.6 | 88.6 | 88.5 | 88.5 | 88.4 | 88.4 | 88.3 | 88.3 | 88.3 | 88.3 |
| Average shares (diluted) | 88.7 | 88.9 | 88.6 | 88.6 | 88.5 | 88.6 | 88.4 | 88.4 | 88.3 | 88.3 | 88.3 | 88.6 |
| Dividend per share | — | — | 2.00 | — | — | — | — | — | — | — | — | — |
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,575 | 1,112 | 1,186 | 858 | 898 | 1,050 | 1,183 | 1,393 | 1,140 | 708 |
| Current assets | 2,487 | 1,011 | 1,153 | 821 | 862 | 1,008 | 1,144 | 1,382 | 1,130 | 699 |
| Cash and equivalents | 1,040 | 513 | 612 | 805 | 848 | 1,000 | 1,113 | 917 | 1,110 | 693 |
| Short-term investments | 1,150 | 266 | 500 | — | — | — | — | — | — | — |
| Receivables | 287 | 214 | 31.8 | 8.0 | 9.0 | 5.6 | 28.7 | 462 | 17.3 | 2.4 |
| Net property, plant and equipment | 83.0 | 96.6 | 31.1 | 35.3 | 33.7 | 39.9 | 37.1 | 9.3 | 7.1 | 5.6 |
| Current liabilities | 521 | 176 | 125 | 70.9 | 101 | 109 | 149 | 343 | 499 | 643 |
| Accounts payable | 23.9 | 50.5 | 29.9 | 21.5 | 11.8 | 14.3 | 8.2 | 14.8 | 7.6 | 11.7 |
| Total debt | 44.1 | 54.2 | 5.0 | 10.0 | 15.9 | 20.8 | 27.4 | — | — | — |
| Total liabilities | 608 | 217 | 140 | 72.1 | 109 | 143 | 209 | 375 | 504 | 647 |
| Total equity (incl. minority) | 1,967 | 895 | 1,047 | 786 | 789 | 907 | 974 | 1,018 | 636 | 60.8 |
| Retained earnings | 1,351 | 305 | 463 | 218 | 226 | 345 | 412 | 455 | 73.4 | 59.4 |
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,819 | 2,679 | 2,575 | 2,601 | 2,330 | 2,123 | 1,112 | 1,093 | 1,132 | 1,136 | 1,186 | 1,242 |
| Current assets | 2,677 | 2,597 | 2,487 | 2,508 | 2,235 | 2,028 | 1,011 | 990 | 1,030 | 1,094 | 1,153 | 1,214 |
| Cash and equivalents | 1,081 | 1,205 | 1,040 | 1,105 | 948 | 559 | 513 | 604 | 490 | 491 | 612 | 698 |
| Short-term investments | 909 | 830 | 1,150 | 777 | 968 | 230 | 266 | — | — | — | 500 | — |
| Receivables | — | — | 287 | — | — | — | 214 | — | — | — | 31.8 | — |
| Net property, plant and equipment | 137 | 77.6 | 83.0 | 88.1 | 90.1 | 90.7 | 96.6 | 99.1 | 98.1 | 38.6 | 31.1 | 26.1 |
| Current liabilities | 671 | 397 | 521 | 600 | 259 | 151 | 176 | 119 | 143 | 129 | 125 | 112 |
| Accounts payable | — | — | 23.9 | — | — | — | 50.5 | — | — | — | 29.9 | 59.5 |
| Total debt | 90.6 | 40.7 | 44.1 | 46.6 | 49.0 | 51.0 | 54.2 | 56.4 | 59.7 | 4.3 | — | — |
| Total liabilities | 803 | 481 | 608 | 632 | 294 | 189 | 217 | 174 | 203 | 144 | 140 | 114 |
| Total equity (incl. minority) | 2,016 | 2,198 | 1,967 | 1,969 | 2,036 | 1,934 | 895 | 919 | 929 | 993 | 1,047 | 1,129 |
| Retained earnings | — | — | 1,351 | — | — | — | 305 | — | — | — | 463 | — |
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,431 | -316 | 310 | -31.6 | -140 | -92.3 | 327 | -200 | -135 | 675 |
| Depreciation and amortization | 15.2 | 13.7 | 7.4 | 14.1 | 13.0 | 11.0 | 9.2 | 2.1 | 2.0 | 1.6 |
| Capital expenditure | -10.2 | -26.6 | -7.4 | -12.7 | -4.4 | -12.5 | -3.3 | -4.3 | -3.4 | -3.0 |
| Investing cash flow | -895 | 206 | -507 | -12.8 | -4.4 | -12.5 | -3.3 | -3.1 | -2.8 | -3.0 |
| Financing cash flow | 26.9 | 5.7 | 14.1 | -2.8 | -7.4 | -6.6 | -139 | — | 560 | -105 |
| Dividends paid | — | — | — | — | — | — | -132 | — | — | -105 |
| Debt issued | 0.9 | — | — | — | — | — | — | — | — | — |
| Debt repaid | — | -0.3 | -0.9 | -8.8 | -7.4 | -6.6 | -6.4 | — | — | — |
| Effect of exchange rates | -35.8 | 6.4 | -10.1 | 4.2 | 0.7 | -1.4 | 10.1 | 10.1 | -4.2 | 11.6 |
| Net change in cash | 528 | -98.6 | -194 | -43.0 | -152 | -113 | 195 | -193 | 418 | 579 |
| Free cash flow | 1,421 | -343 | 302 | -44.4 | -145 | — | — | — | — | — |
| Levered free cash flow | 1,161 | -287 | 211 | -34.4 | -91.1 | -70.2 | 308 | -300 | -144 | 656 |
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 138 | -166 | 313 | -41.2 | 1,147 | 11.8 | -27.4 | -80.3 | -94.3 | -114 | 126 | -52.7 |
| Depreciation and amortization | 3.3 | 3.0 | 15.2 | — | 3.2 | 3.1 | 13.7 | — | — | 2.1 | 7.4 | — |
| Capital expenditure | — | — | -10.2 | — | — | — | -26.6 | — | — | — | -7.4 | — |
| Investing cash flow | -90.1 | 319 | -374 | 187 | -743 | 35.2 | -68.9 | 192 | 95.5 | -13.5 | -205 | -302 |
| Financing cash flow | -178 | 10.7 | 0.6 | 13.2 | 0.7 | 12.5 | 1.4 | 3.5 | -1.3 | 2.1 | 1.1 | 10.9 |
| Debt issued | — | — | 0.9 | — | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | -0.3 | — | — | — | -0.9 | — |
| Effect of exchange rates | 7.1 | 0.2 | -4.5 | -2.1 | -15.3 | -13.8 | 3.3 | -0.9 | -1.2 | 5.2 | -8.5 | -0.8 |
| Net change in cash | -123 | 164 | -64.2 | 156 | 390 | 45.6 | -91.5 | 115 | -1.4 | -121 | -86.2 | -344 |
| Free cash flow | 138 | -166 | 303 | -41.2 | 1,147 | 11.8 | -54.0 | -80.3 | -94.3 | -114 | 118 | -52.7 |
| Levered free cash flow | 140 | -261 | 295 | 17.7 | 1,152 | -366 | 181 | 114 | 19.2 | -602 | 451 | -393 |
Financial statements of similar companies
Companies in the group: same industry, similar size
